3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow bemiparin: new trials by email Literature Review of bemiparin trials Research Report on bemiparin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 Bemiparin - Covid-19 | Phase 2 | Terminated | Fundación de investigación HM | 81 | 2020-06-04 | 2022-06-07 |
| Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) Bemiparin - Carcinoma, Small Cell | Phase 2 | Terminated | Clinica Universidad de Navarra, Universidad de Navarra | 39 | 2005-06-01 | 2012-06-08 |
| Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients bemiparin (low molecular weight heparin) - Foot Ulcer, Diabetic, Diabetic Angiopathies | Phase 2 / Phase 3 | Terminated | Spanish National Health System | 84 | 2001-06-01 | 2006-11-14 |
COVID-19 (1) · Carcinoma, Small Cell (1) · Diabetic Angiopathies (1) · Diabetic Foot (1) · Small Cell Lung Carcinoma (1) · Thromboinflammation (1)
Clinica Universidad de Navarra, Universidad de Navarra (1) · Fundación de investigación HM (1) · Spanish National Health System (1)
Spain (2)
Albert Font, MD (1) · Ana Blasco Cordellat, MD (1) · Antonio Cubillo, MD (1) · Antonio Lorenzo, MD (1) · Bartolomeu Massuti, MD (1) · Dolores Isla, MD (1) · Eduardo Rocha, MD (1) · Enrique Gonzalez, MD (1) · Isidoro C. Barneto, MD (1)
PMID 24491267, PMID 33337539, PMID 35244208
2004 (1)